Primary Cells

Human Chronic Lymphoid Leukemia Bone Marrow Mononuclear Cells (Relapsed/Refractory)

  • For research use only

Cat No.

ABC-TC3343

Product Type

Immune Cells

Cell Type

Mononuclear Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Bone Marrow

Disease

Chronic Lymphoid Leukemia

Storage

Liquid Nitrogen

Human CLL Bone Marrow Mononuclear Cells (Relapsed/Refractory) support immune profiling, biomarker discovery, and therapy response in R/R CLL research.

Product Image

Description

Human Chronic Lymphoid Leukemia Bone Marrow Mononuclear Cells (Relapsed/Refractory) are isolated from the bone marrow of patients with clinically diagnosed chronic lymphocytic leukemia (CLL) who have experienced disease relapse or failed to respond to standard therapies. These mononuclear cells include a heterogeneous population of lymphocytes and monocytes. CLL B cells within the population are small, round lymphocytes with condensed chromatin and scant cytoplasm, growing in suspension. The cells are cryopreserved immediately after isolation without further culturing or passage, ensuring high viability and biological relevance. Relapsed/refractory CLL cells often show resistance to conventional treatments, and may express altered levels of key markers such as CD5, CD19, and CD23. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

Human Chronic Lymphoid Leukemia Bone Marrow Mononuclear Cells (Relapsed/Refractory), Human CLL Bone Marrow Mononuclear Cells, Bone Marrow Mononuclear Cells, BMMCs, MNCs

Species

Human

Cat.No

ABC-TC3343

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Bone Marrow

Disease

Chronic Lymphoid Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Immune Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • These primary CLL bone marrow mononuclear cells serve as a robust model for investigating mechanisms of drug resistance, immune evasion, and BCR pathway signaling in relapsed/refractory CLL, providing a valuable system for refractory CLL studies. They are valuable in evaluating novel therapeutic agents, especially BCL2 inhibitors, BTK inhibitors, or CAR-T cell approaches. Researchers may also use them to study tumor-microenvironment interactions and to characterize CLL immune cell profiles These cells are also used in co-culture systems to assess T cell dysfunction and immune suppression in the CLL bone marrow niche.

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Chronic Lymphoid Leukemia Bone Marrow Mononuclear Cells (Relapsed/Refractory)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button